Skip to main content
Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
1.530
-0.010 (-0.65%)
At close: Nov 4, 2024, 4:00 PM
1.520
-0.010 (-0.68%)
After-hours: Nov 4, 2024, 6:22 PM EST

Quince Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Quince Therapeutics stock have an average target of 11.5, with a low estimate of 11 and a high estimate of 12. The average target predicts an increase of 651.63% from the current stock price of 1.53.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $11 $11.5 $12 $12
Change +618.95% +651.63% +684.31% +684.31%

Analyst Ratings

The average analyst rating for QNCX stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Oct '24
Strong Buy 2
Buy 0
Hold 0
Sell 0
Strong Sell 0
Total 2

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Elemer Piros
Rodman & Renshaw
 Rodman & Renshaw
Strong Buy
Initiates
$11
 Strong Buy Initiates $11 +618.95% Oct 29, 2024
Jason Kolbert
EF Hutton
 EF Hutton
Strong Buy
Initiates
$12
 Strong Buy Initiates $12 +684.31% Oct 22, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.16
from -0.84
EPS Next Year
-0.32
from -1.16
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
--------
Revenue Growth
--------
EPS
-1.94-2.63-3.03-1.54-0.84-1.16-0.32-0.14
EPS Growth
--------
Forward PE
--------
No. Analysts -----333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025
High n/a n/a
Avg n/a n/a
Low n/a n/a

Revenue Growth

Revenue Growth 20242025
High - -
Avg - -
Low - -

EPS Forecast

EPS 202420252026
High -1.20 -0.33 -0.15
Avg -1.16 -0.32 -0.14
Low -1.12 -0.30 -0.14

EPS Growth

EPS Growth 202420252026
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.